Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Lightbridge to Serve on Industry Advisory Board of $6 Million DOE-Funded Project with Penn State
-
Condominiums: Still the Most Affordable Option Despite Rising Costs
-
Picard Medical Reports Full Year 2025 Financial Results
-
Dr. Bob Akmens & BASports.com Capture 7th Las Vegas MLB Exhibition Season Title in 9 Years
-
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
-
NetraMark Announces Strategic Oncology Research Collaboration with Fondazione per la Medicina Personalizzata to Analyze Landmark ROME Trial Dataset
-
CMG Announces the Acquisition of Rose Subsurface Assessment
-
Westhaven Engages San Diego Torrey Hills Capital for Investor Relations
-
Algernon Health Announces NOVASCAN NEUROIMAGING CLINICS™ as the New Brand Name for its U.S. Brain PET Scanning Centers
-
Koryx Copper Announces Updated Mineral Resource Estimate for the Haib Copper Project, Southern Namibia
-
Garrett Motion to hold Technology and Investor Day on Wednesday May 20, 2026 in New York City
-
NexGold Initiates 30,000-Metre Infill Drill Program at the Goldboro Gold Project in Nova Scotia
-
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
-
Maze Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Highlights
-
Maze Therapeutics Announces Positive Topline Data from Phase 2 HORIZON Trial of MZE829 Demonstrating the First Clinical Proof-of-Concept in Patients with Broad APOL1-Mediated Kidney Disease
-
Dr. Bob Akmens & BASports.com Capture 7th Las Vegas MLB Exhibition Season Title in 9 Years
-
Endogenex Closes $50 Million Series C Extension to Fund Pivotal Clinical Study and Path to FDA Approval
-
C4 Therapeutics Announces First Patient Dosed in Phase 1b Trial of Cemsidomide in Combination with Elranatamab (ELREXFIO®) for Relapsed/Refractory Multiple Myeloma
-
Biolojic Design Earns Preclinical Milestone from Teva for First AI-Designed Multibody in Autoimmune Disease, TEV ‘325 (formerly BD9)
-
Winnebago Industries Reports Second Quarter Fiscal 2026 Results
-
Tilray Brands to Announce Third Quarter Fiscal Year 2026 Financial Results on April 1, 2026
-
Notch Raises $30 Million to Bring Production-Ready AI Agents to Regulated Industries
-
Energous Wireless Power Solutions Reports Fiscal Year 2025 Results
-
Verano to Report First Quarter 2026 Financial Results on April 30, 2026
-
Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development
-
Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic
-
NOTICE TO THE ANNUAL GENERAL MEETING OF TULIKIVI CORPORATION 2026
-
STS Digital Unveils First-to-Market Structured Products Platform, Partnering with Kraken
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Falcon Oil & Gas Ltd. - Further Update on Transaction with Tamboran
-
Falcon Oil & Gas Ltd. - Further Update on Transaction with Tamboran
-
Wowza's Elliot Miller Joins Colorado PBS12 Board of Directors
-
NOV Announces Expansion of Subsea Flexible Pipe Manufacturing Capacity to Support Growing Demand
-
Akamai Launches Brand Guardian to Help Enterprises Combat Automated Fraud
-
PDD Holdings Announces Fourth Quarter 2025 and Fiscal Year 2025 Unaudited Financial Results
-
BOSS Zhipin Continues Share Repurchase Program; Cumulative Repurchases Reach Nearly RMB450 Million in FY26
-
ADMA Biologics Addresses Misleading Short-Seller Report
-
Amaze Highlights First Quarter 2026 Achievements and Upcoming Priorities in Letter to Shareholders
-
Back to the Roots Unveils Comprehensive Organic Soil Collection, Now Available Nationwide
-
Dimensional Fund Advisors Ltd. : Form 8.3 - JUST GROUP PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CAPRICORN ENERGY PLC - Ordinary Shares
-
ZenoWell Announces Strategic Cooperation with USound to Explore Advanced Sensing Technologies for Next-Generation Wearable Devices
-
Magic Mushroom Gummies See Record Demand In 2026 As Budpop Reports Selling 280,000 Units In The U.S. Market
-
PBS Cellular Selects Qvantel to Power New MVNO Services
-
Comstock to Participate in the Lytham Partners 2026 Industrials & Basic Materials Investor Summit on April 1, 2026
-
Most Potent THCA Flower Brand in 2026: Exhale Wellness Ranked #1 for Potency and Quality by Sarasota Magazine
-
Particula Launches the Digital Asset Risk Passport (PDARP) - Programmable Risk Infrastructure for On-chain Capital Markets
-
Auddia Announces LT350 Micro Warehouse Network in Parking Lots for Last Mile Delivery
-
Canadian heat pump owners are overwhelmingly satisfied, with 91% recommending one: survey
-
Philadelphia Job Market Shows Strategic Resilience in Q1 2026 as Tech and AI Integration Lead the Way

